Globeflex Capital L P decreased its stake in UnitedHealth Group Inc (NYSE:UNH) by 10.8% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 4,209 shares of the healthcare conglomerate’s stock after selling 510 shares during the period. Globeflex Capital L P’s holdings in UnitedHealth Group were worth $1,120,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in UNH. Welch Group LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $106,000. FNY Investment Advisers LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $106,000. Fort L.P. bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $119,000. Polaris Greystone Financial Group LLC bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $120,000. Finally, Columbia Asset Management bought a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $152,000. 85.45% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group stock opened at $281.36 on Monday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. The company has a market cap of $270.68 billion, a P/E ratio of 27.94, a PEG ratio of 1.62 and a beta of 0.78. UnitedHealth Group Inc has a 1-year low of $208.48 and a 1-year high of $285.45.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The business had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. During the same quarter in the previous year, the company earned $2.66 EPS. The business’s quarterly revenue was up 12.4% compared to the same quarter last year. Research analysts expect that UnitedHealth Group Inc will post 12.82 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be paid a $0.90 dividend. The ex-dividend date is Friday, November 30th. This represents a $3.60 dividend on an annualized basis and a yield of 1.28%. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
In other UnitedHealth Group news, Director Richard T. Burke sold 6,090 shares of the business’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total value of $1,715,674.80. Following the completion of the transaction, the director now owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Kenneth Irwin Shine sold 163 shares of the business’s stock in a transaction that occurred on Friday, November 9th. The stock was sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. In the last three months, insiders sold 60,428 shares of company stock valued at $16,232,134. Corporate insiders own 0.87% of the company’s stock.
Several analysts have recently issued reports on the stock. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, November 21st. BMO Capital Markets set a $310.00 target price on shares of UnitedHealth Group and gave the stock a “buy” rating in a report on Tuesday, November 27th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $310.00 target price on shares of UnitedHealth Group in a report on Wednesday, November 21st. Oppenheimer upped their target price on shares of UnitedHealth Group from $295.00 to $300.00 and gave the stock an “outperform” rating in a report on Wednesday, November 28th. Finally, Piper Jaffray Companies upped their target price on shares of UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a report on Wednesday, November 28th. Two investment analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $292.48.
TRADEMARK VIOLATION WARNING: “Globeflex Capital L P Lowers Holdings in UnitedHealth Group Inc (UNH)” was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2018/12/03/globeflex-capital-l-p-lowers-holdings-in-unitedhealth-group-inc-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.